Funder: National Institutes of Health (NIH)
Due Dates: March 26, 2025 (New applications) | February 24, 2025 (Earliest submission)
Funding Amounts: Up to $1.5 million in direct costs per year | Project period up to 5 years | 4-5 awards anticipated
Summary: Supports multidisciplinary research programs to discover and develop new approaches to prevent, diagnose, and treat antibiotic-resistant bacterial infections.
Key Information: Clinical trials are not allowed; applications must target specific antibiotic-resistant bacterial pathogens; foreign organizations are eligible.